Skip to main content
Terug
Watch Compare

Quoin Pharmaceuticals, Ltd.

Datakwaliteit: 83%
QNRX
NASDAQ Manufacturing Chemicals
€ 6,49
▲ € 0,19 (3,02%)
6 months return
—
Momentum
Neutral
ROE
-2364,66%

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-2364,66%
Onder sectorgemiddelde (-54,47%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio1,04
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-0,64 | -1,87
Boven sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -13,54 M

Price History

Financiële Trends

Koersdoel Analisten

3 analisten
Strong Buy
+357.1%
upside to target
Huidig
€ 6,49
Consensus Target
€ 29,67
€ 14,00
Laag
€ 40,00
Hoog
Vooruitzicht
Forward K/W
-1,87
Forward WPA
-€ 3,15
Omzet Sch.
0,0

Winstverassingen

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -€ 2,26 · Rev Est: 0,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -€ 6,50 -€ 6,27 -€ 6,70 -€ 1,74 — —
Estimate -€ 4,20 -€ 4,55 -€ 1,92 -€ 4,02 -€ 2,26 -€ 2,17
Verrassing -54,81% -37,88% -248,78% +56,72% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -2364,66% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -15,80 M
ROE -2364,66% ROA -206,11%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -13,54 M
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 1,04
Debt / Equity N/A Current Ratio 1,04
Interest Coverage N/A Asset Turnover N/A
Working Capital 250.779 Tangible Book Value -1,62 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,64 · EV/EBITDA: N/A
P/E Ratio -0,64 Forward P/E -1,87
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -132,88%
Market Cap 10,19 M Enterprise Value 8,36 M

Per Share

EPS: N/A · FCF/Share: -7,51
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -7,51 OCF / Share -7,51
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 85,68% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 85,68%
SBC-Adj. FCF -14,72 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 0,0
Net Income -15,80 M -8,96 M -8,69 M -9,38 M -21,46 M
EPS (Diluted) — — — — -0,01
Gross Profit — — — — —
Operating Income — — — — —
EBITDA — — — — —
R&D Expenses 9,80 M 3,60 M 3,31 M 2,67 M 1,56 M
SG&A Expenses 6,49 M 5,93 M 6,07 M 6,58 M 4,50 M
D&A — — — — —
Interest Expense — — — — 1,09 M
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 20,39 M 15,71 M 12,17 M 14,46 M 9,36 M
Total Liabilities 7,27 M 6,50 M 6,51 M 7,05 M 8,70 M
Shareholders' Equity 13,12 M 9,20 M 5,66 M 7,41 M 657.032,0
Total Debt — — — — —
Cash & Equivalents 3,82 M 3,62 M 2,40 M 2,86 M 7,48 M
Current Assets 20,01 M 14,93 M 11,29 M 13,37 M 8,50 M
Current Liabilities 5,55 M 4,18 M 3,58 M 3,53 M —

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -0,6 -1,5
P/B — 1,6
ROE % -2364,7 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3